Session PDFs DDL19

Afresa™ and the Technosphere® Technology
Dr. Peter Richardson, MannKind Corporation, USA

Investigation of Physical Changes in Drug-Carrier Interactive Mixtures on Blending
Dr David Morton, Victorian College of Pharmacy, Australia

Applying Quality by Design Principles to Analytical Methods Associated with Orally Inhaled and Nasal Drug Products
Dr Andrew Rignall, AstraZeneca R & D Charnwood, UK

An Application of Quality by Design (QBD) and Process Analytical Technology (PAT) to the Development of Force-Driven Dose Counters for Pressurized Metered Dose Inhalers
Mr Peter Scarrott, Trudell Medical International, Canada

Optimising Dry Powder Inhaler Design For Children – A Multi-Disciplinary Investigation
Dr Iain Simpson, Team Consulting Limited, UK

Importance of Wall Collisions for Particle-Particle Detachment in Dry Powder Inhalers, and Advanced Wall Collision Models
Dr Ed Wynn, ANSYS UK Limited, UK

Advancing Inhaler Performance through Airflow Management
Mr Prashant Kakade, Map Pharmaceuticals, Inc, USA

Can systemic Drug Delivery via the Pulmonary Tract be achieved with a Dry Powder Inhaler? Lessons learned from Exubera
A H de Boer, University of Groningen, Germany

Inhalation Profiles through the Prohaler Dry Powder Inhaler in Healthy Subjects, and in Patients with Asthma or Chronic Obstructive Pulmonary Disease
Dr Steve Newman, Scientific Consultant, UK

Last Breath on Everest, the Pleasure and the Pain
Flight Lieutenant Ted Atkins, RAF, UK

Rapid Pre-formulation Screening of Drug Salts for Dry Powder Inhalers
H. Harris [1], J.Shur [1], J. Clarke [2], E. French [2] and R Price [1]
[1] University of Bath, [2] Pfizer Global R&D, UK.

PEG-Based Positively Charged Nanoparticles for Pulmonary Delivery of Nucleic Acids
K Sharma [1], S Somavarapu [1], KMG Taylor [1] & N Govind [2]
[1] School of Pharmacy, University of London, [2] AstraZeneca R&D Charnwood, UK

I want to use material X in an OINDP: What do I need to do?
A Feilden
AstraZeneca, R&D Charnwood, UK

Novel Use of a Modified Ink-Jet Print Head to Produce Spray-Freeze Dried Particles for Inhalation
Jacob Harker [1], Chung-Tony Li [2], Simon Gaisford [2] & Matthew Jones [2]
[1] Pfizer, UK, [2] Department of Pharmaceutics, School of Pharmacy, University of London

Combination Particles Containing Fluticasone Propionate and Theophylline for Lung Delivery
Amandeep Singh Dhillon, Chonladda Pitchayajittipong, Jagdeep Shur, Robert Price
University of Bath

Open Innovation in the Inhalation Field: Academia and Industry as Partners
Philippe G Rogueda
Novartis Horsham Research Centre, UK

Times are a changing: The shift in partnership between academia and industry
Prof. Robert Price
University of Bath, Department of Pharmacy and Pharmacology

AmorFx ACADEMIC CONSORTIUM
P.G. Royall [1], M. Saunders [2], R. Price [3] M. O’Neill [4] & S. Gaisford [2]
[1] King’s College London, [2] Synectix Pharmaceutical Solutions Ltd, UK, [3] University of Bath, [4] University of London

Academic & Contract Research: Symbiotic or Parasitic
Prof. Marc Brown
CSO, MedPharm Ltd, UK

Departure from Tradition : Addressing the needs of the Industry
Dr Marcel de Matas
Pharmaceutical Innovation, University of Bradford

Academic / Industry / Spin out interactions – drivers for inhalation innovation
Prof Graham Buckton
Pharmaterials Ltd, UK

Botox for the Lungs?
Dr Duncan Rogers
National Heart and Lung Institute, UK

Nanometer Trojan horses
Dr Giuseppe Battaglia
University of Sheffield, UK

Pre-Clinical models of respiratory disease
Dr D Spina, Sackler
Kings College London, UK

Maintenance of pDNA Viability Following Aerosolisation
[1] Bains BK, [1] Taylor G, [2] Toon R, [2] Jinks P and [1] Birchall JC
[1] Welsh School of Pharmacy, UK, [2] 3M Drug Delivery Systems, UK.

Preclinical Toxicology for Inhaled Drugs – Practicalities and Implications
K Owen
Drug Safety R&D, Pfizer Global R&D, UK

Controlled release formulations using polymer-based dry powders for pulmonary drug delivery
R Cartier, M Krüger, T Bouyssou
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany

The Influence Of Nanoparticle Charge And Hydrophobicity Upon Translocation Across Respiratory Epithelial Cell Layers
S. A. Jones, M. Madlova, I. Zwerschke, Y Ma, R. C. Hider, B. Forbes
King’s College London

UK Respiratory Research Collaborative
Professor Stephen Holgate
University of Southampton